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The balance between nephron progenitor cell (NPC) renewal, survival and differentiation ultimately
determines nephron endowment and thus susceptibile to chronic kidney disease and hypertension.
Embryos lacking the p53-E3 ubiquitin ligase, Murine double minute 2 (Mdm2), die secondary to p53-
mediated apoptosis and growth arrest, demonstrating the absolute requirement of Mdm2 in embry-
ogenesis. Although Mdm2 is required in the maintenance of hematopoietic stem cells, its role in renewal
and differentiation of stem/progenitor cells during kidney organogenesis is not well deﬁned. Here we
examine the role of the Mdm2-p53 pathway in NPC renewal and fate in mice. The Six2-GFP::Cretg/þ
mediated inactivation of Mdm2 in the NPC (NPCMdm2/) results in perinatal lethality. NPCMdm2/
neonates have hypo-dysplastic kidneys, patchy depletion of the nephrogenic zone and pockets of
superﬁcially placed, ectopic, well-differentiated proximal tubules. NPCMdm2/ metanephroi exhibit
thinning of the progenitor GFPþ/Six2þ population and a marked reduction or loss of progenitor markers
Amphiphysin, Cited1, Sall1 and Pax2. This is accompanied by aberrant accumulation of phospho-γH2AX
and p53, and elevated apoptosis together with reduced cell proliferation. E13.5–E15.5 NPCMdm2/
kidneys show reduced expression of Eya1, Pax2 and Bmp7 while the few surviving nephron precursors
maintain expression ofWnt4, Lhx1, Pax2, and Pax8. Lineage fate analysis and section immunoﬂuorescence
revealed that NPCMdm2/ kidneys have severely reduced renal parenchyma embedded in an expanded
stroma. Six2-GFP::Cretg/þ; Mdm2f/f mice bred into a p53 null background ensures survival of the GFP-
positive, self-renewing progenitor mesenchyme and therefore restores normal renal development and
postnatal survival of mice. In conclusion, the Mdm2-p53 pathway is essential to the maintenance of the
nephron progenitor niche.
& 2014 Elsevier Inc. All rights reserved.
Introduction
The total endowment of nephrons is species speciﬁc and is
completed either before or around birth (Hendry et al., 2011).
Renal hypodysplasia (RHD) involving reduced nephron numbers
and smaller disorganized kidneys is a congenital anomaly account-
ing for 20% of pediatric end-stage renal disease. The resulting renal
insufﬁciency predisposes individuals to hypertension, glomerulo-
sclerosis and chronic kidney disease (Keller et al., 2003; Myrie
et al., 2011; Walker and Bertram, 2011). Mutations in some of the
prominent renal development genes such as TCF2, PAX2, EYA1,
SALL1 and SIX1 have been linked to RHD associated chronic renal
insufﬁciency (Weber et al., 2006).
In the deﬁnitive mouse kidney, the metanephric mesenchyme
becomes speciﬁed into the stromal mesenchyme and the non-
homogenous cap mesenchyme (CM) between E11.0 and E11.5
(Kobayashi et al., 2008). The nephron progenitor cells (NPCs) are
Six2þ/Cited1þ and reside exclusively within the CM on the dorsal/
cortical aspect of the branching UB tips. The NPCs within this
niche although self-renewing, stay poised for differentiation/
epithelialization when exposed to appropriate inducing factors
such as the Wnts. Cited1 expression is downregulated with
epithelial differentiation and formation of small mesenchymal
aggregates (PTA, pre-tubular aggregates) ventro-lateral to the UB
tips. The PTAs continue to express low levels of Six2 in addition to
Wnt4. The process of mesenchymal to epithelial transition con-
verts the PTA into a renal vesicle (RV) which begins to express
other epithelial markers in addition to Wnt4, among them Lef1,
and Pea3 (Mugford et al., 2009; Park et al., 2007). Each RV
‘transforms’ sequentially into comma-shaped and s-shaped bodies
via the processes of elongation, segmentation, and patterning and
ultimately forms a nephron. Multiple secreted factors (e.g., Fgf20,
Fgf9, Fgf2, Bmp7, Wnt9b) and transcription factors (such as Osr1,
Eya1, Pax2, Six1/4/2, Sall1) act coordinately to ensure the survival
and renewal of the NPCs long enough to establish the full
complement of nephrons by birth (Barak et al., 2012; Blank
et al., 2009; Brown et al., 2011; Denner and Rauchman, 2013;
Hendry et al., 2011; Oxburgh et al., 2011). This is achieved by
balancing self-renewal and commitment/differentiation processes
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to form the requisite nephron numbers prior to the depletion of
the NPCs within the niche.
Mdm2 is an E3 ubiquitin ligase which targets the tumor suppressor
protein p53 for proteosomal degradation. The pro-survival role of
Mdm2 has been reported in the context of both normal tissue
development and in malignancies. Das et al. (2012) reported that
elevated Mdm2 coupled to low p53 is permissive to maintaining the
‘stemness’ of human embryonic stem cells following oxidative stress.
The corollary being that elevated levels of p53 following oxidative
stress/hypoxia results in cell death or differentiation. Negative regula-
tion of p53 function was also important to ensure the survival of
neuronal progenitors (Francoz et al., 2006). It was demonstrated that
the suppression of p53 functions by Mdm2 is necessary for the self-
renewal and proliferation of intestinal progenitor cells in mouse
neonates (Valentin-Vega et al., 2008). In this study we examine the
role of Mdm2 in NPC renewal and commitment to differentiation
within the developing mouse kidney.
Materials and methods
Animals
All experiments involving mice were conducted in compliance
with guidelines outlined by the institutional IACUC. Mice
harboring the Six2-GFP::Cretg/þ transgene were a kind gift from
Dr. A. P. McMahon. TheMdm2f/f mice (01XH9, Dr. Mary Ellen Perry)
and the p53f/f mice (008462, generated by Dr. Anton Berns) were
obtained from the NCI mouse repository (Frederick, MD), while the
conventional p53 / mice as well as the R26-tdTomato reporter
strain ((007909 Hongkui Zeng) were purchased from the Jackson
Laboratory (Maine, USA). The speciﬁcations for genotyping were
furnished by the respective contributors of animals. All animals in
this study were maintained on a mixed background. The Six2-GFP::
Cretg/þ ;Mdm2 ﬂox/þ mice were bred to Mdm2ﬂox/ﬂox mice in the
experimental breedings. The age of embryos in timed matings was
approximated by designating noon of the day the vaginal plug was
detected as embryonic (E) day 0.5. For the rescue experiments we
bred Six2-GFP::Cretg/þ; p53ﬂox/þ; Mdm2ﬂox/þ mice to p53þ /;
Mdm2ﬂox/ﬂox mice.
Gross morphology
Phase images of the kidneys were captured with a SMZ1000
stereomicroscope ﬁtted with DS-Fi1 camera enabled by the NIS-
Elements F2.20 software.
Histology
Routine Hematoxylin and Eosin staining (Richard Allan Scien-
tiﬁc) was performed on age matched wild type and mutant kidney
sections (4 μm thick). The protocol used was as per the man-
ufacturer0s instructions.
Quantitative reverse transcriptase-PCR
Quantitative reverse transcriptase-PCR was performed on total
RNA isolated from E14.5 kidneys from littermate embryos repre-
senting the genotypes NPCMdm2þ /þ , NPCMdm2þ / , NPCMdm2 /
using the RNeasy Mini Kit (Qiagen). Real-time primer-probe mixes
were ordered from Applied Biosystems (Table 1). qRT-PCR was
done using the Taqman RNA-to-CT 1step kit (4392938; Applied
Biosystems, New York, U.S.A). The thermal proﬁle used was as
follows: 48 1C for 15 min, 95 1C for 10 min and 40 cycles of 95 1C
Table1
List of primer-probe mix used for qRT-PCR.
Gene name Catalog number Exon boundary
Pax2 Mm01217939_m1 Exons 8–9
Wnt4 Mm01194003_m1 Exons 1–2
Fgf8 Mm00438922_m1 Exons 5–6/4–5
Fgf9 Mm01319105_m1 Exons 2–3
Wnt9b Mm00457102_m1 Exons 3–4
Fgf7 Mm00433291_m1 Exons 2–3
Bmp7 Mm00432102_m1 Exons 3–4
Eya1 Mm00438796_m1 Exons 8–9/9–10
Gdnf Mm00599849_m1 Exons 1–2
60XGAPDH VIC PL 99999915_g1
Table 2
List of antibodies used in the immuno-staining assays
Primary antibody Cat# Source Working dilution Method
Mouse anti-E-cadherin 610181 BD Biosciences 1:100 IF
Rabbit anti-Six2 11562-1-AP Proteintech group 1:200 IF
DAPI D1306 Invitrogen 1:400 IF
LTA FL-1321 Vector Laboratories 1:100 IF
Rabbit anti-Cleaved PARP (D214) 9544S Cell Signaling 1:200 IF with TSA
Rabbit mAb to Beta-catenin (6B3) 9582S Cell Signaling 1:800 IF with TSA
Rabbit anti AGT Gift:Dr. John Chan Univ. of Montreal; Quebec, Canada 1:100 IF
Chicken anti GFP ab13970 Abcam 1:400 IF
Rabbit anti-p53 NCl-p53-CM5p Leica Novacastra 1:200 DAB
Rabbit anti-CITED1 RB-9219-P Thermo Scientiﬁc 1:50(300 RT) DAB and IF
Rabbit anti-Pax2 716000 Invitrogen 1:100 IF
Goat anti-AQP2 (C17) sc-9882 Santa Cruz 1:100 IF
Rabbit anti-WT1 (C-19) sc-192 Santa Cruz 1:100 IF
Mouse mAb to MEIS1/2/3 (Clone9.2.7) 39795 Active Motif 1:100 IF with TSA
Mosue anti-Lhx1 4F2-c DHB 1:100 IF with TSA
Rabbit anti-pHistone H3 (S10) 9701S Cell Signaling 1:100 IF
Rabbit anti-Cleaved Caspase3 (D175) 9661s Cell Signaling 1:100 IF
Rabbit anti Laminin L9393 Sigma 1:100 dil IF
Goat polyclonal anti-DsRed (C-20) sc-33354 Santa Cruz 1:200 IF
Rabbit anti-amphiphysin 13379-1-AP Proteintech 1:200 dil IF
Mouse Anti-Six2 mAb (0.1mg) H00010736-M01 Abnova 1:100 IF with TSA
Rabbit anti-WT1 ab15249 Abcam (1:100) IF
Rabbit anti-Sal 1 Gift: Dr. M. Rauchman/Susan Kiefer St. Louis Univ. HSC, Missouri, USA 1:1000 dil IF
Mouse anti-NCAM C9672 Sigma 1:200 IF
Rabbit anti-H2AX gamma (pS139) ab11174 Abcam 1:100 IF
Mouse anti-Six2 Mab H00010736-M01 Abnova 1:100 IF
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for 15 s, 55 1C for 1 min and 72 1C for 1 min. The reactions were
performed in triplicate. The relative transcript levels were calculated
using the ΔΔCt method with GAPDH as the endogenous normal-
izing gene. Three independent experiments using total RNA from
kidneys of representative genotypes from age-matched litters were
used in our assays. The scale bars represent the standard error of
mean of average values. P value was calculated using the two-tailed
Student’s T test with po0.05 considered as signiﬁcant.
Fig. 1. Loss of Mdm2 function in the Six2 expressing nephron precursor cells (NPCs) cause bilateral renal hypodysplasia. (A–C) Gross morphology of the urogenital system
from control NPCMdm2þ /þ (A), NPCMdm2þ / (B), and NPCMdm2/ embryos (C). Note the much smaller kidneys (red arrow heads) in C. (D–F, D0–F0) H and E staining of kidney
sections from control (D, D0), NPCMdm2þ / (E, E0), and NPC Mdm2/ (F, F0) embryos reveals regionalized loss of the nephrogenic zone in the NPCMdm2/ mutant kidneys
(arrowhead in panel F). BL, urinary bladder; NZ, Nephrongenic zone; PT, proximal tubules. (G–J) Cortical displacement of proximal tubules in the NPCMdm2/ newborn
kidneys. (G, I) NPCMdm2þ /þ and (H, J) NPCMdm2 / kidneys at P0. Co-staining for LTA and angiotensinogen (AGT) both markers of the proximal tubules reveals their ectopic
distribution (white arrow heads in H, J) in the mutant kidneys. Differentiation and maturation of proximal tubules do not appear to be affected in the mutants.
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Immuno-staining
Tissues were ﬁxed in 10% formalin at 4 1C and dehydrated prior
to parafﬁn embedding. Four micron tissue sections were cleared in
xylene and rehydrated in a graded series of ethanol prior to
antigen retrieval in 10 mM sodium citrate (pH6.0). Endogenous
peroxidase was quenched by incubating slides in 3% hydrogen
peroxide at room temperature. Sections were blocked for 90 min
at room temperature in 0.5% blocking reagent (Perkin-Elmer
FP1012) in Tris-buffered saline supplemented with 10% normal
donkey serum together with unconjugated, monovalent donkey
anti-Rabbit Fab (711-007-003 Jackson immunoresearch laboratories,
Inc., PA) and donkey anti-Mouse Fab (715-007-003) fragments at
15 μl/ml each. The primary antibodies used are listed in Table 2.
For secondary detection we used donkey anti-rabbit, donkey
anti-mouse, donkey anti-goat or goat anti-chicken as was required
and conjugated to one of the following Alexaﬂuor dyes: Alexa-
Fluor555, AlexaFluor488 or AlexaFluor 647 (Molecular Probes,
Invitrogen). For IF using Tyramide Signal Ampliﬁcation we used
the TSA ﬂuorescence kit (Perkin Elmer NEL760001KT) as per the
manufacturer0s recommendations.
Images were captured using the deconvolution Olympus (IX51)
microscope using the Metamorph software version 7.0 (Molecular
Devices Corporation, U.S.A). For DAB detection we used the
peroxidase based Vectastain ABC elite kit (Vector laboratories,
Inc.CA) or peroxidase conjugated ImmPRESS REAGENT anti-Rabbit
Ig (MP-7401, Vector Labs) and the chromagen kit Vector NovaRed
Substrate Kit (SK4800, Vector Labs).
TUNEL assay
Recombinant Terminal Deoxynucleotidyl transferase (rTdT)
mediated nick-end labeling (TUNEL) was performed using the Dead
End Fluorometric Tunel System (Promega) according to the man-
ufacturer0s guidelines. Brieﬂy, four-micron parafﬁn sections were
incubated in proteinase K at 20 μg/ml for 8–10min at room tempera-
ture. The sections were pre- and post-ﬁxed in paraformaldehyde. The
sections were incubated with the nucleotide mixture which included
ﬂuorescein-tagged dUTP and rTdT enzyme for an hour at 37 1C. The
slides were incubated in DAPI (Vector Laboratories, Inc.) at 1:500
working dilution for 15min at room temperature. Quantitative
analysis of apoptotic foci to area ratio was determined using Slidebook
4.1 (Digital Microscopy Software).
In situ hybridization
The protocol used was described previously (Hilliard et al.,
2011; Saifudeen et al., 2009). The samples were ﬁxed overnight in
4% PFA/PBS and then dehydrated through a graded alcohol series
before parafﬁn embedding. Sections were cut to 10 μm thickness.
The non-radioactive RNA probes carried a digoxigenin label which
was detected using anti-digoxigenin Fab fragments coupled to
alkaline phosphatase (Roche Diagnostics). BM purple was used as
the chromogenic substrate for alkaline phosphatase.
Results
Metanephric development requires functional Mdm2
As it is detailed in our earlier publication (Hilliard et al., 2011),
Mdm2 is expressed ubiquitously in the embryonic kidney at E14.5.
Accordingly, it is detected in the branching ureteric bud (UB), the cap
mesenchyme (CM), nephron intermediates, as well as in the stroma
(Hilliard et al., 2011; Supplemental Fig. S1). Previously, we showed that
Fig. 2. (A–H) Expression of the transgene, Six2-GFP::Cre at representative stages.
Phase and GFP ﬂuorescence images of heterozygous (A, C, E, G) and homozygous
mutant kidneys (B, D, F, H) at E12.5 (A–D) and E16.5 (E–H). The GFP ﬂuorescence is
detectable in the cap mesenchyme. The NPCMdm2/ kidneys show much weaker
GFP expression (D, H). (I–M) NPCMdm2 / kidneys show a noticeable reduction in
the Six2-positive cells of the cap mesenchyme. Control and mutant kidney sections
at E14.5 (I, J) and E16.5 (K, L) respectively, were stained for E-cadherin (green) and
Six2 (red). Nuclei were stained with DAPI (blue). The Six2-positive cap mesench-
yme was several layers thick and more robust in the controls (I, K) unlike the
NPCMdm2/ mutant kidneys which show a thinner cap, reduced to 1–2 cell layers
in thickness. (M) A graph showing a four-fold difference in the Six2-staining area
(normalized to the DAPI area) between control and mutant kidneys (p¼0.008).
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Mdm2 regulation of p53 is indispensable for the formation of the renal
collecting duct in the embryonic kidney (Hilliard et al., 2011).
In the present study, we examined the functional contribution
of Mdm2 to the process of nephrogenesis. This was accomplished
by a Six2-GFP::Cretg (Park et al., 2007) mediated inactivation of
ﬂoxed Mdm2 alleles in the Six2þ nephrogenic niche. The Six2-
GFP::Cretg; Mdm2F/F mice (hereafter referred to as NPCMdm2 /)
were born at normal Mendelian ratios but died within the ﬁrst few
days of birth owing to severe renal malformation. The NPCMdm2 /
 kidneys were small and hypo-dysplastic with an undulating
contour (with crests and troughs) compared to wild type litter-
mate controls (NPCMdm2þ /þ) (Fig. 1 A–F, D0–F0). Assessment of
their histology revealed that these undulations coincided with
pronounced, precocious depletion of the nephrogenic zone in the
‘trough-like’ regions of the mutant kidneys (Fig. 1F,F0). This is
reminiscent of the renal phenotype reported in Fgf9þ /;
Fgf20βgalβgal compound mutant mice (Barak et al., 2012). Second,
the proximal tubules (LTAþ , AGTþ) were superﬁcially displaced in
the neonatal NPCMdm2 / kidneys (Fig. 1H, J). Normally, this occurs
postnatally around P3–P4 in the mouse following the cessation of
nephrogenesis and the depletion of all nephrogenic progenitors
(Rumballe et al., 2011). These proximal tubules acquire some
segmental maturation since they are AGT positive but occur as
disorganized clusters in the conditionally null mutant kidneys
(Fig. 1G–J).
Mdm2 supports the survival of NPCs within the cap mesenchyme
To better understand the basis for premature depletion of the
nephrogenic zone in NPCMdm2 / kidneys, we examined the mutant
kidneys during organogenesis. Kobayashi et al. (2008) have reported
that the Six2-GFP::Cretg transgene is expressed in the CM from the
Fig. 3. Signiﬁcant loss of key molecular markers of the self-renewing nephron progenitor population in NPCMdm2/ kidneys at E14.5. Comparison of Six2 (A, B), Cited1 (C,
D), Sall I (E, F), and Amphiphysin (G, H) staining in NPCMdm2þ /þ (A, C, E, G) and NPCMdm2/ (B, D, F, H) littermate kidneys.
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onset of metanephric development at E10.5. We found strong GFP
ﬂuorescence conﬁned to the CM in the heterozygous mutant kidneys
(NPCMdm2þ /) at E12.5, E13.5 (not shown), and E16.5 (Fig. 2C, G). By
contrast, the GFP expression in the NPCMdm2/ kidneys appeared
weak and patchy, reminiscent of a smaller CM (Fig. 2D, H). This
apparent reduction of the CM was evident in the mutant kidneys at
E11.75 and E12.5 by Six2 and Pax2 immuno-staining (Supplemental
Fig. S2). By E14.5 there is a four-fold reduction in the Six2þ NPCs in
the mutants compared to wild type kidneys (Fig. 2I–M). The few
surviving Six2þ cap cells form a thin layer on the dorsal aspect of the
UB tips, failing to extend more ventrally as in Bmp7 / mutant
kidneys (Blank et al., 2009; Brown et al., 2013).
To determine if the loss of Six2 reﬂects a true depletion of the
NPCs, we compared Cited1 expression in wild type and NPCMdm2 /
kidneys. The combined expression of Six2 and Cited1 marks the
NPCs. Immuno-staining revealed a dramatic reduction of Cited1
expression in NPCMdm2/ kidneys at E14.5 (Fig. 3C, D). Thus the
NPCMdm2 / kidneys showed a signiﬁcant loss of the Six2þ Citedþ
NPC subpopulation within the CM. Staining for other markers of the
metanephric mesenchyme such as Amphiphysin (Karner et al., 2011)
and Sall1 (Nishinakamura et al., 2001) corroborated the regionalized
depletion of the dorsal cap mesenchyme cell population at E14.5
(Fig. 3E–H).
Conditional inactivation of Mdm2 upregulates p53 and DNA damage
in the NPCs
Mdm2, an E3 ubiquitin ligase, has a prominent role in the
regulation of p53 stability and half-life by targeting it for proteosomal
degradation. Therefore, we examined the impact of CM-speciﬁc loss
of Mdm2 on p53 expression levels. We observed a notable elevation
in p53 immunoreactivity in the Six2 promoter driven GFPþ CM
surrounding the UB branch tips at E13.5 (Fig. 4A,B). Unlike the GFP
expression which was conﬁned to the CM, p53 was up-regulated in
Fig. 4. The NPCMdm2/ kidneys show accumulation of p53 protein as well as phospho-H2AXγ in the CM. (A, B) E13.5 kidney sections from NPCMdm2 / mice show elevated
expression of p53 speciﬁcally in the CM cells which stain positively for GFP. Compared to NPCMdm2þ /þ (not shown) and NPCMdm2þ / kidneys (C), the NPCMdm2 / kidneys
(D) continue to show a marked increase in p53 expression levels at E14.5. There is co-localization of Six2 and phospho-H2AXγ in NPCMdm2/ but not in the control
NPCMdm2þ /þ kidneys (E–H, arrow heads in H).
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the CM as well as in the cells of the nascent nephrons derived from
the cap (not shown). Thus the functional ablation of Mdm2 in the
NPCs resulted in stabilization of p53 levels. Surprisingly, although
Mdm2 is ubiquitously expressed (Supplemental Fig. S1) the elevation
in p53 was punctuated at E13.5 and at E14.5 (Fig. 4A–D). This could
be attributed to either the chimeric expression of the Six-GFP:: Cre
transgene, or could be reﬂective of differences in p53 oscillations
within the non-homogeneous CM. Next, we examined the cellular
outcomes of persistent p53 levels. First, we looked for any evidence
of double-stranded DNA breaks in the CM cells of mutant kidneys by
staining for phosphorylated H2AXγ alongside Six2. Notably the
mutant kidneys revealed cells that are Six2þ and phospo-H2AXγþ
indicative of cells that have sustained DNA damage (Fig. 4E–H).
Stabilization of p53 in response to genotoxic stress is known to result
in cell cycle arrest, apoptosis or cellular senescence. Therefore, we
examined the levels of cell apoptosis and cell proliferation in the
mutant kidneys relative to littermate wild type controls at E14.5
(Figs. 5 and 6). Quantitation of TUNEL positive foci in whole kidney
sections was similar in NPCMdm2þ /þ and NPCMdm2/ mice (Fig. 5D).
However, the spatial distribution of apoptotic foci was remarkably
different between the two (Fig. 5A–E). In mutant kidneys, the
apoptotic cells were primarily distributed in the cortical, nephrogenic
zone; the NPCMdm2 / kidney sections have 4.9 fold more apoptotic
cells in the cortex relative to the NPCMdm2þ /þ kidneys, p¼0.04
(Fig. 5E). In comparison, subcortical and medullary regions showed
no signiﬁcant differences in apoptosis in mutants and controls. Our
observation on cell apoptosis was further corroborated by co-staining
for Six2 or pan cytokeratin and cleaved Parp-1, another marker of
apoptosis (Supplemental Fig. S3). Immuno-staining for the mitotic
cell marker, phospho-histone H3 (pHH3), revealed that Mdm2 loss in
the Six2þ NPCs also resulted in reduced cell proliferation in the
kidney as a whole (1.7 fold, Fig. 6). It should be noted that the
combined pHH3- and Six2-positive foci when normalized to Six2-
positive cells revealed no change in mitotic rates between the wild
type control and mutant kidney.
Mdm2 ensures the survival and timely differentiation of NPCs and
nephron lineage cells
Using whole mount and section in situ hybridization we
assayed for key molecular markers of nephron progenitors and
the differentiating nascent nephrons originating from them. At
E13.5 and E14.0, the expression of Eya1 and Pax2 was signiﬁcantly
lower in the CM of the mutant kidneys (Supplemental Fig. S4A–D).
Wnt4 expression was not affected (Supplemental Fig. S4E, F), while
Gdnf expression was slightly lower (Supplemental Fig. S4G, H),
and, the stromal marker Foxd1 showed strong up-regulation in the
cortical aspect of NPCMdm2/ kidneys (Supplemental Fig. S4I, J).
There were far fewer nascent nephrons (control kidneys have 3-
fold more over the mutant kidneys) expressing Fgf8, Pax8, Pax2,
Wnt4, and Lhx1 in the E14.5–E15.5 NPCMdm2/ kidneys (Fig. 7).
Next we examined the secondary effects of Mdm2 loss from the
Fig. 5. (A–E) The NPCMdm2 / kidneys show signiﬁcant elevation in apoptosis by TUNEL assay. Sections of E14.5 NPCMdm2þ /þ kidneys (A) show largely subcortical apoptotic
foci. By contrast, in the NPCMdm2 / kidneys (B) there are numerous apoptotic foci in the cortical, nephrogenic zone including the dorsal aspect of ureteric bud tips. (A0 , B0)
Panels showing wild type and mutant kidney sections co-stained for Six2 following TUNEL assay to highlight the presence of apoptotic cells in the cap mesenchyme of only
the latter. (C) A graph showing a signiﬁcant increase (4.9 fold, p¼0.04) in TUNEL-positive apoptotic foci in the cortical regions of NPCMdm2 / kidneys relative to control
kidneys. (D) Counts of apoptotic foci in complete kidney sections (cortex, sub-cortex, and medulla) or in regions interior to the cortex remain unchanged or show an
insigniﬁcant drop in apoptosis (n¼7 animals per genotype).
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CM on the UB lineage. The expression of UB markers cRet, Wnt9b,
and Wnt11 was comparable between the wild type controls and
NPCMdm2/ kidneys at E13.5 (Supplemental Fig. S5). However,
there were large areas in the E15.5 NPCMdm2/ kidneys, which
probably correspond to regions with premature depletion of the
nephrogenic zone, that were devoid of cRet-, Wnt9b- and Wnt11-
positive structures (Supplemental Fig. S5).
To obtain further corroboration of our in situ data we per-
formed qRT-PCR on E14.5 total RNA from NPCMdm2þ /þ and
NPCMdm2/ kidneys from age matched embryos (Supplemental
Fig. S6). While Gdnf expression was not altered Eya1 levels
were much lower in the NPCMdm2 / kidneys. The reduction in
Pax2, Fgf8, and Bmp7 and the elevated levels of Fgf7 and Wnt9b
were statistically signiﬁcant. Although we did not detect a sig-
niﬁcant drop in Fgf9 levels in NPCMdm2 / kidneys at E14.5 it may
exert some synergistic effects when coupled to low Bmp7 in our
model. It should be noted that we observed enhanced Wnt9b
expression by qRT-PCR but not by ISH.
By immuno-staining the deﬁnitive markers of nephrogenesis we
were able to better characterize the defects in NPCMdm2 / kidneys at
E14.5 (Fig. 8). There were fewer Lhx1þ and Pax2þ , nephron inter-
mediates evident at E14.5 (Fig. 8A–F). The presence of some nephron
precursors in the mutant kidneys can be attributed to the normal
differentiation of a small population of Six2þ progenitors that escape
Six2-Cre mediated recombination. The absence of ectopic/dorsal renal
vesicles (Lamininþ and pan cytokeratin negative) in the NPCMdm2 /
kidneys discounts the possibility that the Six2þ NPC population
undergoes precocious differentiation en masse (Fig. 8G–J).
By breeding the R26-tdTomato reporter mice with the Six2-GFP::
Cretg; Mdm2F/F mice, we found that despite the inactivation of
Mdm2, dsRedþ nephron precursors representing all the morpho-
genetic steps were being speciﬁed at E13.5 (not shown) and E14.5
(Supplemental Fig. S7). Lef1, a marker of the nephron precursors,
appeared lower in the nephron intermediates of the NPCMdm2/
kidneys. The recovery of Lef1þ , dsRedþ nascent nephrons in the
mutant kidneys suggests that the NPCs retain their potential to
differentiate into all stages of the nephrogenic lineage despite the
inactivation of Mdm2 in these cells. Furthermore, by co-staining for
Six2, dsRed, and Meis1 at E13.5 and P0 (data not shown) we were
able to conﬁrm that the Six2þ cells do not undergo a fate change
into stromal cells. This is further borne out by the co-localization of
the Lef1 and dsRed staining at E14.5 (Supplemental Fig. S7). None-
theless, we do observe localized cortical expansion of the Meis1þ
stroma dorsal to the thinning cap in the mutant kidneys. Dual
staining with PCNA and Meis1 conﬁrms that the stroma undergoes
increased proliferation regionally in the mutant kidneys (Fig. 9).
Fig. 6. Co-staining for Six2 and phospho-histoneH3 (pHH3) reveals fewer mitotic cells in the NPCMdm2/ kidneys when compared to wild type controls. Representative
sections from control (A) and mutant (B) kidneys at E14.5. The boxed area in A and B is shown enlarged in C and D respectively. (E) A graph showing the average number of
pHH3-positive foci in control and mutant kidney sections at E14.5 (1.7 fold change; T-test, p value¼0.03). (F) Comparison of mitotic rates with respect to the Six2-positive
cap mesenchyme shows no signiﬁcant difference between control and mutant kidneys (n¼4 for NPCMdm2þ /þ; n¼5 for NPCMdm2 /).
S.A. Hilliard et al. / Developmental Biology 387 (2014) 1–148
Taken together, Mdm2 is essential for the maintenance of both
the NPCs and the nephron precursors being speciﬁed from
them. Increased p53 levels in the wake of Mdm2 loss within
the NPC lineage results in elevated apoptosis of the nephron
progenitors and precursors causing premature cessation of
nephrogenesis.
Inhibition of p53 by Mdm2 is essential to maintain the nephrogenic
niche
We see accumulation of p53 protein following Six2-Cre
mediated recombination of both Mdm2 ﬂoxed alleles in the NPCs
(Fig. 4B,D). To determine if the poor survival of the NPCs and the
resulting renal hypodysplasia can be circumvented by the elim-
ination of p53 function, we bred these mice into a p53 null
background. The combined loss of Mdm2 and p53 in the NPCs is
able to rescue kidney development. These compound mutant mice
survive to adulthood and are fertile (Table 3).
Gross and histological analyses of the NPCMdm2 /p53 /
kidneys reveal a near complete rescue (Fig. 10). Accordingly, the
nephrogenic zone with its nascent ureteric tips, multi-layered cap,
and nascent nephrons was maintained and the differentiated
epithelia tubules were subcortical to it as in the control wild type
littermates. Notably, Six2Creþ NPCs that stain positive for GFP
were recovered in NPCMdm2 / , p53/ kidneys but not in the
homozygous mutant or heterozygous kidneys at birth (Fig. 11A–C
and data not shown). The recovery of GFP expressing CM cells
attests to the survival role of Mdm2 in the niche. Also noteworthy
was the recovery of the Cited1þ , Six2þ and Pax2þ NPC subpopu-
lation in the CM of compound mutants (Fig. 11D–L). In addition,
the Meis1-staining stroma and nephron intermediates being
speciﬁed (Lhx1þ structures) were restored to wild type levels
(Fig. 11J–L and data not shown). Therefore, the suppression
of p53 function by Mdm2 is necessary to maintain the NPC
population.
Discussion
The nephrogenic niche houses the progenitor population that
gives rise to the full complement of nephrons in a given species.
Deﬁcit in the ﬁnal nephron number is seen as a major contributor
of renal diseases in adult life (Keller et al., 2003; Myrie et al., 2011;
Walker and Bertram, 2011). The ‘stemness’ of this population is
maintained by factors that sustain self-renewal capacity in some
cells while rendering others competent to differentiate under the
Fig. 7. Paucity of nascent nephrons in the NPCMdm2/ kidneys at E14.5. ISH for the early markers of nephrons: Fgf8 (A, B), Wnt4 (C, D) and Lhx1 (E, F) reveals far fewer
nephron precursors in NPCMdm2/ kidneys (B, D, F) relative to the littermate NPCMdm2þ /þ kidneys (A, C, E). (G) A graph showing a 3-fold difference in the average number of
nascent nephrons between control and mutant kidneys at this stage (n¼3 per genotype).
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inﬂuence of appropriate cues. Fgf20, Fgf9, Bmp7, Six2 and Sall1
each have essential roles either in the proliferation, survival, or the
continual replenishment of the nephrogenic niche (Barak et al.,
2012; Blank et al., 2009; Brown et al., 2011, 2013; Denner and
Rauchman, 2013; Kobayashi et al., 2008; Oxburgh et al., 2011; Self
et al., 2006). Our study examines the functional contribution of
Mdm2 in the nephrogenic progenitor niche. We found that the
loss of Mdm2 has a signiﬁcant impact on the survival and
maintenance of the NPC population. In the absence of Mdm2
function, elevated p53 and apoptosis within the NPC population
cause their premature depletion. The epithelial nephron precur-
sors that are speciﬁed show poor survival owing to oscillations in
p53 levels in the NPCMdm2 / kidneys. Consequently, the number
of identiﬁable immature nephron intermediates was dramatically
reduced in the NPCMdm2 / kidneys and there is a localized
premature cessation of nephrogeneis at birth.
Liu et al. (2007) have ascribed a role for the Mdm2-p53
network in sustaining progenitor cell expansion during postnatal
mouse development. In that study mice lacking Mdm2 coupled to
an apoptosis-deﬁcient, hypomorphic p53 allele (p53515C) showed
Fig. 8. NPCMdm2/ kidneys do not show any ectopically forming nephrons at E14.5. (A–F) Pax2 (red) and Lhx1 (green) co-stainings highlight phenotypes ranging between
mild (B shown enlarged in E) and severe (C shown enlarged in F) in the mutant kidneys. (G–J) Laminin (red) and pan cytokeratin (green) co-stainings show that there are no
ectopic nascent nephrons on the dorsal aspect of the Ub tips in NPCMdm2 / E14.5 kidneys as with the control littermate kidneys. Panels I and J are enlarged views of G and H
respectively.
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widespread defects in progenitor expansion within both the neural
and hematopoietic lineages. Renal failure in these mice was
attributed to delayed nephron development, which resulted in
fewer glomeruli that were poorly developed. Later, Abbas et al.
(2010) demonstrated that Mdm2 keeps reactive oxygen species
(ROS)-induced p53 levels in check to allow hematopoiesis to
proceed postnatally in the same mouse model. In the absence of
Mdm2, there is a stabilization of p53 in the hematopoietic
progenitors within the bone marrow. Stabilized, p53 transactivates
ROS-inducing genes (also known as p53-induced genes, PIG) that
cause death of the hematopoietic cells (Donald et al., 2001; Li
et al., 1999; Polyak et al., 1997). In our study, we ﬁnd phospho-
H2AXγ-positive cells in the surviving CM cells of NPCMdm2 /
kidneys but not in the wild type control kidneys. Phospho-H2AXγ-
positive staining is indicative of double-stranded DNA breaks
possibly triggered by p53-induced ROS. Therefore, in the absence
of the protective inﬂuence of Mdm2 there is stabilization of p53,
p53-mediated induction of the pro-oxidant state leading up to
stress-induced double-stranded DNA breaks and ultimately apop-
tosis of cells. Taken together, we conclude that Mdm2 is important
for the survival and expansion of the nephrogenic progenitor
population during metanephrogenesis similar to its role in the
neural and hematopoietic lineages postnatally.
The renal phenotype resulting from the conditional loss of
Mdm2 from the NPCs is strongly reminiscent of Fgf9þ /; Fgf20βGal/
βGal compound mutant kidneys described by Barak et al. (2012).
Similar to the Fgf9þ /; Fgf20βGal/βGal kidneys, the NPCMdm2 /
kidneys were reduced in size with large regions that are devoid of
the nephrogenic zone with few functional glomeruli. It is likely
that the NPCs were prematurely depleted, through elevated p53
and apoptosis, and therefore made fewer nephrons.
An important aspect of the renal phenotype in NPCMdm2 /
kidneys is the expanded stromal cell population. Although the
precise reasons for cortical stroma expansion in mutant Mdm2
kidneys are unknown, our lineage fate studies (Supplemental Fig.
S7) suggest that the extra stroma is not derived from “Six2-Cre”
cells. Rather, increased PCNA staining in the cortical stroma of
NPCMdm2 / kidneys argues that proliferation accounts for the
observed expansion of the stromal population. Recent research has
demonstrated the importance of signals originating in the cortical
stroma that oppose NPC renewal but promote its differentiation
(Das et al., 2013). In the absence of cortical stroma they observed
an expansion of the nephron progenitors. The NPCMdm2/ kid-
neys show regionalized expansion rather than loss of the cortical
Fig. 9. The cortical stroma of NPCMdm2/ mice is multi-layered and shows an increase in PCNA expression. (A, C, E) Sections through NPCMdm2þ /þ and (B, D, F) NPCMdm2/
kidneys at E14.5. Regionalized elevation in PCNA staining is observed in the cortical stromal cell population of NPCMdm2/ kidneys (B, D). (E, F) The cortical stroma (white
arrows) of the mutant kidney is several cell layers thick unlike the wild type littermate control kidneys (compare Meis1 expression in panels E and F).
Table 3
Rescue of NPCMdm2/ mice against a p53 null background.
Postnatal day 21
n¼71
Mdm2F/þ Mdm2F/F CreþMdm2F/þ CreþMdm2F/F
p53 F/ 4 3 5 6
p53 F/þ 5 11 5 0
p53þ/ 8 6 5 0
p53/ 4 2 1 2
p53þ/þ 1 2 1 0
All genotypes expected at 1:20 ratio.
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stroma. It is possible that the expanded stroma in our model
opposes NPC renewal while elevation in p53 mediated apoptosis
reduces NPC survival within the nephrogenic niche.
A recent report revealed an essential role for Bmp7/Smad
signaling in the spatio-temporal transition of Cited 1-positive
NPC cells into Six2-positive cells, which represents a cell
Fig. 10. Loss of p53 from NPCMdm2/ kidneys can rescue metanephrogenesis. (A, C, E, G) Gross morphology of kidneys at P0; (B, D, F, H) H & E staining of kidney sections
from corresponding genotypes. (A, B) NPCp53þ /þ ; Mdm2þ /þ wild type control; (C, D) NPCp53þ /þ ; Mdm2/ homozygous null mutant for Mdm2 but wild type for p53; (E, F)
NPCp53þ / ; Mdm2 / homozygous null mutant for Mdm2 but heterozygous for p53; (G, H) NPCp53/ ; Mdm2 / compound homozygous null mutant for Mdm2 and p53.
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population committed to nephron formation upon induction by
canonical Wnts (Brown et al., 2013). In agreement with this
observation, Bmp7 / mice have small, hypomorphic kidneys
owing to the premature cessation of nephrogenesis stemming
from the survival of only a few Cited1þ cells and greatly reduced
Six2þ cell population. The conditional loss of Mdm2 from the
NPCs also results in small, hypoplastic kidneys that are severely
deﬁcient in Cited1, Six2, Sall1 and Amphiphysin. The pronounced
loss of Cited1þ cells in our model could be indicative of poor
survival of the NPCs and/or their premature commitment to the
process of epithelialization preceding nephron differentiation.
The association between Mdm2-p53 signaling and ‘stemness’
has been reported previously. Human embryonic stem cells rely on
high MDM2 and low p53 levels to maintain stemness and
regenerative capacity (Das et al., 2012). Suppression of p53 levels
allows cytoprotection while maintaining an undifferentiated state.
On the other hand, high p53 levels promote apoptosis and
differentiation of human embryonic stem cells following oxidative
stress. In our model Mdm2 may function to maintain low p53
levels in the nephrogenic niche to ensure ‘stemness’ and prevent
precocious depletion of the CM. Immuno-detection of the Cre
reporter tdTomato using DsRed revealed that Cre was active in the
CM and their differentiated epithelial derivatives. In other words,
the loss of the Six2þ cap mesenchyme could not be attributed to a
fate change to Meis1þ stromal population.
A previous study shows that several tissues deﬁcient in Mdm2
function exhibit spontaneous activation of p53 in the absence of
post-translational modiﬁcation (Ringshausen et al., 2006). Recently,
Pant et al. (2013) using a genetic mouse model demonstrated that
basal levels of Mdm2 can sufﬁciently regulate p53 levels to ensure
normal tissue homeostasis. In our study, the elimination of Mdm2
from the NPCs of the embryonic kidney led to p53 accumulation and
widespread apoptosis in the nephrogenic zone cells predominantly
in the mesenchyme capping the UB. Curiously, we did not detect
enhanced acetylation of p53 in the absence of Mdm2 function in the
NPCs (data not shown). Normally Mdm2 recruits HDAC1 to facilitate
the deacetylation of p53 which makes it susceptible to ubiquitin-
mediated proteosomal degradation (Ito et al., 2002). Therefore, our
ﬁndings support the idea that elevation of unmodiﬁed tissue p53
levels is sufﬁcient to cause apoptosis in vivo.
In summary, Mdm2 through its regulation of the pro-apoptotic,
growth-suppressive protein, p53, is essential for the renewal/
survival of NPCs. Without functional Mdm2, there is a stabilization
of p53 levels accompanied by elevated apoptosis and premature
depletion of the Six2þ cap cells accounting for premature cessa-
tion of nephrogenesis.
Fig. 11. Restoration of nephrogenesis in compound, homozygous mutant NPCp53 / ;Mdm2 / newborn kidneys. P0 control kidneys NPCp53þ /þ ;Mdm2þ /þ (A, D, G, J);
conditional Mdm2 mutants, NPCp53þ /þ ; Mdm2/ (B, E, H, K); compound homozygous mutants NPCp53/ ; Mdm2 / (C, F, I, L). (A–C) Six2 (red) and GFP (green) co-staining
underscores the recovery of GFPþ cap mesenchyme cells absent from NPCp53þ /þ ;Mdm2/ kidneys (Compare B and C). (D–F) Cited1 (red, blue arrows) expressing
subpopulation within the cap mesenchyme is lost in NPCp53þ /þ ;Mdm2 / kidneys but is maintained in a p53 null background (Compare E and F). (G–I) The proportion of cap
mesenchyme (Six2þ , red) to cortical stroma (Meis1þ , green) is re-established in the compound mutant kidneys as shown in panel I. (J–L) Pax2 (red) and Lhx1 (green)
immuno-staining reveal that Ub branching and renal tubule differentiation and survival can be supported in NPC p53 / ; Mdm2 / kidneys unlike the single mutants
NPCp53þ /þ ; Mdm2 / . The rescued kidneys show a well developed nephrogenic zone (NZ) with normally patterned cortical parenchyma and interstitium.
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